Drug profile · INN
felbamate
FELBAMATE
felbamate (FELBAMATE) is a glutamate [nmda] receptor antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — felbamate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
felbamate (FELBAMATE) is a glutamate [nmda] receptor antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Glutamate [NMDA] receptor antagonist
Primary target: Glutamate [NMDA] receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is felbamate?
felbamate (FELBAMATE) is a glutamate [nmda] receptor antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for felbamate?
FELBAMATE is a marketed brand name for felbamate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of felbamate?
felbamate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.